Karyopharm Therapeutics, Inc. (KPTI)

Last Year

19-Apr-23 -- 18-Apr-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drug Manufacturers - Major

Drugs

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

16

0

7

+1

0

+2

0

+3

Two Year Chart

19-Apr-22 -- 18-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
12-Sep-23 4:07 PM View:	12-Sep-23 Private Purchase $49.99K	Bohlin Garen G Director		Karyopharm Therapeutics, Inc. - KPTI	1029% 4.0K to 45.14K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 7:38 PM View:	01-Mar-24 Sale ($4.29K)	Mano Michael SVP, General Counsel&Secretary		Karyopharm Therapeutics, Inc. - KPTI	90% 146.12K to 277.85K	0	0	--	--	Show Txns Hide Txns

05-Apr-24 5:20 PM View:	04-Apr-24 Sale ($4.60K)	Paulson Richard A. President and CEO Director		Karyopharm Therapeutics, Inc. - KPTI	42% 816.62K to 1.16M	0	0	--	--	Show Txns Hide Txns

04-Mar-24 7:41 PM View:	01-Mar-24 Sale ($7.16K)	Rangwala Reshma EVP & Chief Medical Officer		Karyopharm Therapeutics, Inc. - KPTI	112% 165.0K to 349.72K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 7:40 PM View:	01-Mar-24 Sale ($7.39K)	Poulton Stuart EVP, Chief Development Officer		Karyopharm Therapeutics, Inc. - KPTI	107% 159.13K to 329.51K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 7:39 PM View:	01-Mar-24 Sale ($7.39K)	Mason Michael EVP, CFO & Treasurer		Karyopharm Therapeutics, Inc. - KPTI	63% 245.36K to 398.76K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 7:37 PM View:	01-Mar-24 Sale ($6.13K)	Cheng Sohanya Roshan EVP & Chief Commercial Officer		Karyopharm Therapeutics, Inc. - KPTI	84% 213.34K to 393.51K	0	0	--	--	Show Txns Hide Txns